What type of study is this?

This is a Cohort Study study (also classified as: Quantitative Study).

September 28, 2025United European Gastroenterology JournalOpen Access

Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort

View Full Paper

Ask AI

Bookmark

The study found that oral contraceptive use increases pancreatic ductal adenocarcinoma risk in females.
A significant association was observed where each full-term pregnancy decreased pancreatic ductal adenocarcinoma risk.
Higher levels of sex hormone-binding globulin were linked to a decreased risk of pancreatic ductal adenocarcinoma in males.
Machine learning models demonstrated high accuracy in identifying pancreatic ductal adenocarcinoma risk factors across both sexes.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis shows hormone exposure affects pancreatic ductal adenocarcinoma risk in both sexes, indicating potential preventive strategies.

Cite This Study

Peduzzi et al. (2025) studied this question.

synapsesocial.com/papers/68d9051441e1c178a14f49bf https://doi.org/10.1002/ueg2.70102

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis shows hormone exposure affects pancreatic ductal adenocarcinoma risk in both sexes, indicating potential preventive strategies.

Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort

Key Points

Discussion

Implication

Cite This Study

Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider